Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDHL
2276
Redhill Biopharma
RDHL
$3.74M
| $1.67M | ﹤0.01% |
302
+124
| +70% | +$950K |
|
|
ACGN
2277
DELISTED
Aceragen Inc
ACGN
| $1.67M | ﹤0.01% |
35,485
+9,416
| +36% | +$1.08M |
|
2278
Valero Energy
VLO
$100B
| $1.67M | ﹤0.01% |
22,233
+10,674
| +92% | +$938K |
|
2279
Editas Medicine
EDIT
$488M
| $1.67M | ﹤0.01% |
+73,243
| New | +$1.99M |
|
|
NETI
2280
DELISTED
Eneti Inc.
NETI
| $1.66M | ﹤0.01% |
32,367
-24,548
| -43% | -$1.4M |
|
2281
AeroVironment
AVAV
$7.46B
| $1.66M | ﹤0.01% |
24,359
-4,219
| -15% | -$370K |
|
2282
Sierra Bancorp
BSRR
$512M
| $1.65M | ﹤0.01% |
68,799
+26,790
| +64% | +$719K |
|
2283
TriMas Corp
TRS
$1.44B
| $1.65M | ﹤0.01% |
60,589
-44,270
| -42% | -$1.26M |
|
|
TSG
2284
CALL
DELISTED
The Stars Group Inc.
TSG
| $1.65M | ﹤0.01% |
100,000
| – | – |
|
2285
Zumiez
ZUMZ
$311M
| $1.65M | ﹤0.01% |
86,059
+73,980
| +612% | +$1.57M |
|
|
CEPU
2286
Central Puerto
CEPU
$2.06B
| $1.65M | ﹤0.01% |
179,076
+71,615
| +67% | +$678K |
|
|
REVG
2287
DELISTED
REV Group
REVG
| $1.65M | ﹤0.01% |
+219,294
| New | +$2.5M |
|
2288
New York Times
NYT
$11B
| $1.65M | ﹤0.01% |
73,844
-661,086
| -90% | -$16.8M |
|
|
CYAD
2289
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| $1.65M | ﹤0.01% |
90,597
+37,171
| +70% | +$897K |
|
2290
Vermilion Energy
VET
$1.87B
| $1.64M | ﹤0.01% |
77,963
+12,463
| +19% | +$324K |
|
|
HNGR
2291
DELISTED
Hanger Inc.
HNGR
| $1.64M | ﹤0.01% |
86,647
-231,219
| -73% | -$4.47M |
|
|
HK
2292
DELISTED
Halcon Resources Corporation
HK
| $1.64M | ﹤0.01% |
965,412
-6,227,012
| -87% | -$19.5M |
|
2293
Universal Health Services
UHS
$10.5B
| $1.64M | ﹤0.01% |
14,062
+9,999
| +246% | +$1.26M |
|
|
XOG
2294
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $1.64M | ﹤0.01% |
382,135
+204,760
| +115% | +$1.52M |
|
|
VVNT
2295
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $1.64M | ﹤0.01% |
166,000
| – | – |
|
|
BRSS
2296
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $1.63M | ﹤0.01% |
64,981
+29,390
| +83% | +$911K |
|
2297
Univest Financial
UVSP
$1.15B
| $1.63M | ﹤0.01% |
75,726
-511
| -0.7% | -$12.4K |
|
2298
CALL
VanEck Oil Services ETF
OIH
$1.92B
| $1.63M | ﹤0.01% |
+5,805
| New | +$2.3M |
|
2299
WD-40
WDFC
$2.91B
| $1.63M | ﹤0.01% |
+8,888
| New | +$1.51M |
|
|
FARO
2300
DELISTED
Faro Technologies
FARO
| $1.62M | ﹤0.01% |
39,841
+27,888
| +233% | +$1.35M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.